2Morgan MY, Alonso M, Stanger LC. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A random ised, cross-over study. J Hepatol, 1989, 8: 208～ 217.
3Morgan MY, Hawley KE, Stambuk D. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. J Hepatol, 1987, 4: 236～244.
4Horsmans Y, Solbreux PM, Daenens C, Desager JP, Geubel AP. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy. Aliment Pharmacol Ther, 1997, 11: 165～170.
5Conn HO. Subclinical hepatic encephalopathy. In: Conn HO, Bircher J, eds. Hepatic encephalopathy syndromes and therapies. Bloomington, IL, 1994. 27～37.
6Conn HO. A clinical hepatologist's predictions about non-absorbed carbohydrates for the early twenty-first century. Scand J Gastroenterol Suppl, 1997, 222: 88～92.
7Ferenci P. Treatment of hepatic encephalopathy in patients with cirrhosis of the liver. Dig Dis, 1996, 14 Suppl 1: 40～52.
